Vicky Schnell
Reproductive Endocrinology · Webster, TXNPI 1669458881
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Ferring Pharmaceuticals Inc. accounts for 74.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $14,561 and has fallen 80.1% since, to $2,891 in 2025. Among reproductive endocrinology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $180.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$17K
- Granata Bio Corporation$2K
- IBSA Institut Biochimique SA$1K
- Pfizer$942
- Myovant Sciences Inc.$914
- AbbVie$437
- plus $819 from 14 others
Across 277 payments — averaging $20,261 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring International Pharmascience Center US$2.6M
- IBSA Institut Biochimique SA$2.6M
- AbbVie$372K
- Sumitomo Pharma America, Inc.$12K
- Myovant Sciences Inc.$11K
- Myovant Sciences GmbH$4K
What the payments were for
- Consulting fees$12,09252%
- Speaking & faculty fees$1,7457%
- Travel & lodging$5,27823%
- Food & beverage$3,56915%
- Education$6003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 62 | $17,401 |
| Granata Bio Corporation | 3 | $1,571 |
| IBSA Institut Biochimique SA | 1 | $1,200 |
| Pfizer | 2 | $942 |
| Myovant Sciences Inc. | 3 | $914 |
| AbbVie | 22 | $437 |
| EMD Serono, Inc. | 9 | $163 |
| Covidien LP | 5 | $117 |
| Organon | 5 | $110 |
| Merck | 6 | $108 |
| Conmed Corporation | 1 | $63 |
| Myovant Sciences GmbH | 1 | $49 |
| Baxter Healthcare | 1 | $46 |
| Ferring International Pharmascience Center US | 2 | $34 |
| Acessa Health Inc. | 1 | $31 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Intuitive Surgical | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,284 in reported general payments places this provider in the 90th percentile of 142 reproductive endocrinology providers in Texas.
Other reproductive endocrinology in Webster
- John CrochetWebster$10K
- Randall DunnHouston$234K
- Jason GriffithSpring$145K
- Kaylen SilverbergAustin$127K
- Matthew RetzloffSan Antonio$120K
- Kevin DoodyBedford$118K
- Kathleen DoodyBedford$49K
- Robert KauffmanAmarillo$46K
- Satin PatelDallas$32K
- Craig WitzHouston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.